Table 1 Characteristics of the study samples
Characteristic | FinnGen | UK Biobank |
|---|---|---|
No. of individuals | 519,200 | 407,463 |
Age at baseline assessment, mean (s.d.) | 53.1 (17.9) | 56.9 (8.0) |
Age at end of follow-up/death, mean (s.d.) | 60.8 (18.0) | 70.9 (7.9) |
Sex, n (%) | ||
Women | 292,784 (56.4) | 220,208 (54.1) |
Men | 226,416 (43.6) | 187,255 (45.9) |
BMI (kg/m2), mean (s.d.) | 27.35 (5.53) | 27.41 (4.76) |
Missing, n (%) | 142,454 (27.4) | 1273 (0.3) |
Smoking, n (%) | ||
Nonsmoker | 156,355 (50.9) | 221,770 (54.6) |
Former smoker | 70,317 (22.9) | 143,384 (35.3) |
Current smoker | 80,736 (26.2) | 41,109 (10.1) |
Missing | 211,792 | 1,380 |
HFRS, median (IQR) | 5.2 (1.6–10.4) | 1.5 (0–5) |
Women, median (IQR) | 5.3 (1.6–10.5) | 1.5 (0–4.7) |
Men, median (IQR) | 5.0 (1.5–10.3) | 1.5 (0–5.4) |
HFRS categories, n (%) | ||
Low risk (<5) | 241,656 (48.4) | 304,555 (74.7) |
Intermediate risk (5–15) | 188,147 (37.8) | 74,386 (18.2) |
High risk (>15) | 65,925 (13.2) | 28,702 (7.0) |
HFRS > 5, n (%) | 254,874 (51.0) | 101,326 (24.9) |
HFRS > 5 before age 65, n (%) | 95,410 (18.4) | 33,485 (8.2) |
Died during follow-up, n (%) | 62,764 (12.1) | 36,795 (9.0) |
Number of hospitalizations, median (IQR) | 8 (4–17) | 1 (0–3) |
